Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins.
暂无分享,去创建一个
[1] T. Wilczok,et al. Smooth muscle cell apoptosis in primary varicose veins. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[2] P. C. Smith,et al. Immunocytochemical characterisation of the inflammatory cell infiltrate of varicose veins. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[3] Yu Zhang,et al. Differentiation of vascular myofibroblasts induced by transforming growth factor-β1 requires the involvement of protein kinase Cα , 2003 .
[4] J. Bellón,et al. Expression of Elastic Components in Healthy and Varicose Veins , 2003, World Journal of Surgery.
[5] A. Schmidt,et al. Exogenous nitric oxide causes overexpression of TGF-beta1 and overproduction of extracellular matrix in human coronary smooth muscle cells. , 2003, Cardiovascular research.
[6] L. Penning,et al. The effect of TGF-β receptor binding peptides on smooth muscle cells , 2002 .
[7] T. Jacob,et al. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. , 2001, Journal of vascular surgery.
[8] J. Michel,et al. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study , 2001, The Journal of pathology.
[9] M. Jacob,et al. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation , 2000, The Journal of pathology.
[10] G. Schmid-Schönbein,et al. Expression of Adhesion Molecules and Cytokines on Saphenous Veins in Chronic Venous Insufficiency , 2000, Annals of vascular surgery.
[11] G. Pascual,et al. Evaluation of the smooth muscle cell component and apoptosis in the varicose vein wall. , 2000, Histology and histopathology.
[12] T. McCaffrey,et al. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. , 1999, Journal of molecular and cellular cardiology.
[13] Yoram Vodovotz,et al. Regulation of transforming growth factor b1 by nitric oxide , 1999 .
[14] T. Billiar,et al. Nitric oxide as a bifunctional regulator of apoptosis. , 1999, Circulation research.
[15] M. Knaapen,et al. Vascular Remodeling in Varicose Veins , 1998, Angiology.
[16] J P Cooke,et al. Nitric oxide synthase: role in the genesis of vascular disease. , 1997, Annual review of medicine.
[17] A. Zalewski,et al. Transforming Growth Factor-β1 Expression and Myofibroblast Formation During Arterial Repair , 1996 .
[18] L. Greenfield,et al. Classification and grading of chronic venous disease in the lower limbs. A consensus statement. , 1995, International angiology : a journal of the International Union of Angiology.
[19] F. Fowkes,et al. Epidemiology of varicose veins. A review. , 1994, International angiology : a journal of the International Union of Angiology.
[20] M. Callam,et al. Epidemiology of varicose veins , 1994, The British journal of surgery.
[21] O. Petersen,et al. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[22] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[23] T. Jacob,et al. Programmed Cell Death (Apoptosis) and Its Role in the Pathogenesis of Lower Extremity Varicose Veins , 2000, Annals of vascular surgery.
[24] S. Signorelli,et al. Venous stasis causes release of interleukin 1β (IL‐1β), interleukin 6 (IL‐6) and tumor necrosis factor alpha (TNFα) by monocyte‐macrophage , 2000 .
[25] R. Eid,et al. STRUCTURAL CHANGES IN THE TUNICA INTIMA OF VARICOSE VEINS: A HISTOPATHOLOGICAL AND ULTRASTRUCTURAL STUDY , 2000, Pathology.